Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Fluorescent D1 antagonist [SKF83566-green] (AC125)
Cat.#: ASSD-125
Specifications
Description Selective fluorescent D1 dopamine receptor antagonist (apparent KD values are 7.09, < 5 and 7.56 for D1, D2 and D5 receptors respectively). Also antagonizes the activity of SKF 83566, a D1 dopamine receptor agonist. Displays no intrinsic agonist activity. Size 50 μg Applications For imaging at the D1 receptor use solutions up to 100 nM. Molecule Weight 877 Purity >97% Solubility Soluble in DMSO Excitation 488 nm Emission 525/550 nm Storage Store at -20° C Shipping Shipped at 4°C Important We strongly recommend storing this product away from light and briefly sonicating the sample when using to ensure it is fully dissolved and the solution is homogeneous. However, we do not recommend using the product after subjecting it to repetitive freeze-thaw cycles. Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ASSD-173 FITC-Dextran 70 (AC173) 100 mg, 500 mg inquiry ASSD-226 Antifade Fluorescence Mounting Medium (hard set) (AC226) 10 mL inquiry ASSD-115 7-Amino-4-methylcoumarin (AC115) 100 mg, 500 mg, 1 g inquiry ASSD-198 NHS-5(6)Carboxyrhodamine (AC198) 25 mg inquiry ASSD-162 Nile Red (AC162) 25 mg inquiry ASSD-196 5-Carboxyfluorescein (AC196) 100 mg, 250 mg inquiry ASSD-139 Adenosine A1AR Affinity-Based Probe (AfBP) (AC139) 50 μg inquiry ASSD-128 Fluorescent M3 antagonist [pirenzepine] (AC128) 50 μg inquiry ASSD-207 NBD-X acid (AC207) 1 g inquiry ASSD-220 Nitrofluorescein, Isomer 2 (AC220) 1 g inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket